PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

▼
Showing posts with label Avelumab. Show all posts
Showing posts with label Avelumab. Show all posts

Merck KGaA and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab

›
Merck KGaA, Darmstadt and Pfizer announced the initiation of two Phase III studies of avelumab*, an investigational, fully human anti-PD-L1...

Merck KGaA and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015

›
Merck KGaA, Darmstadt, Germany and Pfizer announced that six abstracts on studies evaluating the potential role of programmed death-ligan...
›
Home
View web version
Powered by Blogger.